From a new report that indicates that the use of regulated animals in biomedical research is declining to an editorial arguing for the use of female mice in research, animal research takes center stage in this week’s Research Ethics Roundup.
Conflicts of Interest on Institutional Review Boards Remain Problematic: A recent study in JAMA Internal Medicine concluded that while there has been significant progress with respect to reporting and managing institutional review board (IRB) member conflict of interests, there is still more work to be done. Ed Silverman reports on the findings in this article from The Wall Street Journal’s Pharmalot[...] Read more
This week’s Research Ethics Roundup reflects on the past by exploring revelations that the US government conducted race-based experiments on American troops and considers emerging issues such as China’s growing presence in biomedical research and the move toward single IRB review.
A Scientific Ethical Divide Between China and West: In this article for The New York Times, Didi Kirsten Tatlow explores some ethical concerns that have come to the fore amidst China’s efforts to “become a leader biomedical research.”
Please, Corporations, Experiment on Us: [...] Read more
Traditional research methodologies are being used to address a number of longstanding challenges, including how to make health care more efficient and effective, and how to fight poverty. This week’s Research Ethics Roundup sheds light on the role of research in answering those questions, as well as other stories related to research ethics and oversight.
Don’t Weaken the FDA’s Drug Approval Process: The 21st Century Cures Act proposes significant changes to the approval process for many medical products. In this opinion piece for The New York Times, Gregg Gonsalves, Mark Harington, and David A. Kessler warn that “Congress should [...] Read more
From research being conducted by Facebook to questions raised by a study on public opinion of same-sex marriage, this week's Research Ethics Roundup delves into the world of social and behavioral research. Read on to learn more about these and other stories in the world of research ethics and oversight.
Do You Consent?: In this piece for Slate, James Grimmelmann, JD, considers questions raised by studies conducted by Facebook and other entities outside of the traditional research realm, and considers the role of research oversight in those contexts.
<[...] Read more
In this week's Research Ethics Roundup, we explore how new approaches are being used to address longstanding questions, such as those raised by expanded access or compassionate use, and chart a course for the future of biomedical innovation.
Company Creates Bioethics Panel on Trial Drugs: In an effort to address concerns related to compassionate use requests, Johnson and Johnson announced last week that they have appointed bioethicist Arthur L. Caplan, PhD, to "to create a panel that will make decisions about patients' requests for potentially lifesaving medicine."